Teva Pharmaceutical Industries Ltd (TEVA.N)
23 Feb 2017
Teva Pharmaceutical Industries Ltd has agreed to settle the "vast majority" of the roughly 4,000 lawsuits it faced over its generic version of the heartburn drug Reglan, which has been linked to a serious neurological disorder.
NEW YORK Mick McGuire, founder of activist hedge fund Marcato Capital Management, told CNBC on Monday that Deckers Outdoor Corp had erred by investing significantly in physical retail stores.
NEW YORK, Feb 13 Mick McGuire, founder of activist hedge fund Marcato Capital Management, told CNBC on Monday that Deckers Outdoor Corp had erred by investing significantly in physical retail stores.
* Teva said to weigh options for branded generics to reduce debt - Bloomberg, citing sources
TEL AVIV Teva Pharmaceutical Industries is seeking a new chief executive with deep drug industry experience, the Israel-based company said on Monday as it looks to restore confidence after a series of missteps and the departure of CEO Erez Vigodman.
* Shares in New York up 4 percent in early trade (Recasts with comments about CEO, adds details from conference call, analyst)
* Teva chairman: board has begun search for new CEO with extensive pharmaceutical experience
TEL AVIV, Feb 13 Teva Pharmaceutical Industries reported better-than- expected fourth-quarter profit as sales were boosted by its $40.5 billion acquisition of Allergan's Actavis generic drug business on Aug. 2.
* Allergan CEO "We have a good report card for 2016 and a positive outlook for 2017 and beyond"
TEL AVIV Teva Pharmaceutical Industries was left without a permanent chief executive on Tuesday after Erez Vigodman stepped down, leaving new management to restore confidence in the world's biggest generic drugmaker after a series of missteps. | Video